Clinical Trials Browser

Breast Neoplasms × Triptorelin Pamoate × Clear all

NCT05982093 2026-04-24

SOLTI-2104

Phase 2 Recruiting

Breast Neoplasms

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast Neoplasms

NCT03944434 2025-02-26

FACILE

Phase 2 Active not recruiting

Breast Neoplasms

NCT05800197 2023-04-06

NEMO

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

Breast Neoplasms

NCT02113553 2022-09-10

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Phase 2 Terminated

Breast Neoplasms

NCT00090844 2021-01-28

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Phase 2 Terminated

49 enrolled 10 charts

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04659551 2020-12-09

GIADA

Phase 2 Completed

Breast Neoplasms

NCT00194792 2017-07-11

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

Phase 2 Terminated

28 enrolled 9 charts

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

Phase 3 Terminated

29 enrolled 6 charts

Breast Neoplasms

NCT00659373 2016-07-25

Co-SOFT

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

NCT00311636 2013-06-26

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Phase 3 Completed

Breast Neoplasms